Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C, Zips D, Pönisch F, Evers C, Enghardt W, Abolmaali N, Zöphel K, Appold S, Hölscher T, Steinbach J, Kotzerke J, Herrmann T, Baumann M. Gillham C, et al. Among authors: kotzerke j. Radiother Oncol. 2008 Sep;88(3):335-41. doi: 10.1016/j.radonc.2008.05.004. Epub 2008 May 29. Radiother Oncol. 2008. PMID: 18514339
Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure.
Zschaeck S, Haase R, Abolmaali N, Perrin R, Stützer K, Appold S, Steinbach J, Kotzerke J, Zips D, Richter C, Gudziol V, Krause M, Zöphel K, Baumann M. Zschaeck S, et al. Among authors: kotzerke j. Acta Oncol. 2015;54(9):1355-63. doi: 10.3109/0284186X.2015.1074720. Epub 2015 Sep 23. Acta Oncol. 2015. PMID: 26398663 Clinical Trial.
Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Jentsch C, Bergmann R, Brüchner K, Mosch B, Yaromina A, Krause M, Zips D, Troost EGC, Löck S, Kotzerke J, Steinbach J, Thames H, Baumann M, Beuthien-Baumann B. Jentsch C, et al. Among authors: kotzerke j. Radiother Oncol. 2016 Dec;121(3):447-452. doi: 10.1016/j.radonc.2016.07.024. Epub 2016 Aug 17. Radiother Oncol. 2016. PMID: 27544820
FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
Zschaeck S, Löck S, Leger S, Haase R, Bandurska-Luque A, Appold S, Kotzerke J, Zips D, Richter C, Gudziol V, Schreiber A, Zöphel K, Baumann M, Krause M. Zschaeck S, et al. Among authors: kotzerke j. Radiother Oncol. 2017 Mar;122(3):437-444. doi: 10.1016/j.radonc.2017.01.019. Epub 2017 Feb 17. Radiother Oncol. 2017. PMID: 28222892
Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging.
Löck S, Perrin R, Seidlitz A, Bandurska-Luque A, Zschaeck S, Zöphel K, Krause M, Steinbach J, Kotzerke J, Zips D, Troost EGC, Baumann M. Löck S, et al. Among authors: kotzerke j. Radiother Oncol. 2017 Sep;124(3):533-540. doi: 10.1016/j.radonc.2017.08.010. Epub 2017 Aug 23. Radiother Oncol. 2017. PMID: 28843726
Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients.
Bandurska-Luque A, Löck S, Haase R, Richter C, Zöphel K, Perrin R, Appold S, Krause M, Steinbach J, Kotzerke J, Hofheinz F, Zips D, Baumann M, Troost EGC. Bandurska-Luque A, et al. Among authors: kotzerke j. Clin Transl Radiat Oncol. 2019 Feb 15;15:108-112. doi: 10.1016/j.ctro.2019.02.002. eCollection 2019 Feb. Clin Transl Radiat Oncol. 2019. PMID: 30834349 Free PMC article.
388 results